Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
Journal of Neuropathology and Experimental Neurology|November 18, 2000
"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group StudyH G Brown, J L Kepner, E J Perlman, et al.
Cancer Research|July 1, 1994
Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecanH S Friedman, M E Dolan, S H Kaufmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1992
Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II studyH S Friedman, J P Krischer, P Burger, et al.
Medical and Pediatric Oncology|January 1, 1991
Osteoblastic metastases from astrocytomas: a report of two casesD C Longee, H S Friedman, P C Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
Analysis of DNA mismatch repair proteins in human medulloblastomaS E Lee, S P Johnson, L P Hale, et al.
Radiation Research|February 1, 1992
Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograftD T Laskowitz, G B Elion, M W Dewhirst, et al.
Journal of Neuro-Oncology|May 1, 1996
Treatment of infants with malignant gliomas: the Pediatric Oncology Group experienceP K Duffner, J P Krischer, P C Burger, et al.
Medical and Pediatric Oncology|January 1, 1991
Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem gliomaM Griebel, H S Friedman, E C Halperin, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1989
Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenograftsX M He, S X Skapek, C J Wikstrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1G E Archer, J H Sampson, I A Lorimer, et al.
Pageof 36